Nonetheless, a definitive role for GDF‐15 in the muscle wasting of COPD patients will require the generation of a GDF‐15‐neutralizing antibody that could be used to block GDF‐15 function in humans. This evidence concerns the gene GDF15 and chronic obstructive pulmonary disease.